Vaxart, Inc.

VXRT · OTC Markets OTCQX

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.4%

Institutions0.1%

Public / Other

	You	Peer avg
P/E	2.9	–
Revenue Growth	-31.6%	-53.9%
ROE	67.0%	-107.1%

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-06-30	2016-06-30	2015-06-30
Total money the company brought in from its core business during the period, before any costs are subtracted.	$237.26M	$28.70M	$7.38M	$892000	$4.05M	$9.86M	$4.16M	$8.90M	$9.30M	$24.60M
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$18.07M	-$66.29M	-$83.35M	-$72.75M	-$30.17M	-$15.79M	-$21.76M	-$27.50M	-$25.20M	-$19.50M
Operating income as a percentage of revenue.	7.6%	-231.0%	-1129.5%	-8156.1%	-745.7%	-160.1%	-523.1%	-309.0%	-271.0%	-79.3%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$16.33M	-$66.95M	-$82.47M	-$70.47M	-$32.22M	-$18.64M	-$18.01M	-$29.40M	-$25.40M	-$19.10M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.07	$-0.33	$-0.57	$-0.58	$-0.36	$0.00	$-2.00	$0.00	$0.00	$0.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.07	–	–	–	–	–	–	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-06-30	2016-06-30	2015-06-30
Cash and highly liquid short-term investments the company can access almost immediately.	$53.81M	$25.23M	$34.76M	$143.75M	$126.87M	$13.53M	$11.51M	$17.70M	$49.70M	$44.70M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$186.08M	$166.39M	$91.83M	$221.17M	–	$37.03M	$35.23M	$40.10M	$72.70M	$79.40M
All of the company's interest-bearing borrowings, short and long term combined.	–	–	–	–	–	–	–	$200000	$400000	$200000
Everything the company owes — debt, unpaid bills, and other obligations.	$98.28M	$107.46M	$34.02M	$33.64M	–	$24.08M	$23.99M	$21.40M	$26.50M	$9.90M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$87.80M	$58.92M	$57.80M	$187.53M	–	$12.95M	$11.24M	$18.70M	$46.20M	$69.50M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-06-30	2016-06-30	2015-06-30
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$7.71M	-$44.76M	-$70.45M	-$59.83M	-$23.75M	-$13.09M	-$14.55M	-$30.00M	-$14.10M	-$9.60M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$145000	$554000	$1.87M	$5.16M	$1.22M	$850000	$707000	–	$200000	$100000
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$7.57M	-$45.32M	-$72.32M	-$64.99M	-$24.97M	-$13.94M	-$15.26M	–	-$14.30M	-$9.70M

Vaxart, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Peer Comparison

Income Statement

Balance Sheet

Cash Flow Statement